Company Analysis

Scienture Holdings, Inc. (SCNX)

Nasdaq: SCNX · Pharmaceutical Preparations · Commack, NY · filing with the SEC since 2007
Grade3.1
◀ Past 2.6● Present 2.1▶ Future 4.3
1 est.

Who runs Scienture Holdings, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Narasimhan Mani
President & Co-CEO. First filing Aug 2024, latest Mar 12, 2026, 0 filings in all.
Officers reporting now
3
of 3 people with a filing in the last fifteen months
Directors reporting now
0
14 people on the record since 2014
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Sherb Eric MichaelChief Financial OfficerAug 2026Aug 31, 2026none
Narasimhan ManiPresident & Co-CEOAug 2024Mar 12, 2026none
Shankar HariharanCo-CEO & ChairmanAug 2024Mar 12, 2026none
Earlier names on the record11, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton SCNX · research, not advice